{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T03:29:02Z","timestamp":1793158142524,"version":"4.5.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,11]],"date-time":"2022-03-11T00:00:00Z","timestamp":1646956800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,11]],"date-time":"2022-03-11T00:00:00Z","timestamp":1646956800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS115951"],"award-info":[{"award-number":["R01NS115951"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS088137"],"award-info":[{"award-number":["R01NS088137"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008552","name":"Brigham Research Institute","doi-asserted-by":"publisher","award":["NextGen Award"],"award-info":[{"award-number":["NextGen Award"]}],"id":[{"id":"10.13039\/100008552","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG051812"],"award-info":[{"award-number":["R01AG051812"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG054672"],"award-info":[{"award-number":["R01AG054672"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Microbiome"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      The gut microbiota can affect neurologic disease by shaping microglia, the primary immune cell in the central nervous system (CNS). While antibiotics improve models of Alzheimer\u2019s disease, Parkinson\u2019s disease, multiple sclerosis, and the C9orf72 model of amyotrophic lateral sclerosis (ALS), antibiotics worsen disease progression the in SOD1\n                      <jats:sup>G93A<\/jats:sup>\n                      model of ALS. In ALS, microglia transition from a homeostatic to a neurodegenerative (MGnD) phenotype and contribute to disease pathogenesis, but whether this switch can be affected by the microbiota has not been investigated.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In this\n                      <jats:italic>short report<\/jats:italic>\n                      , we found that a low-dose antibiotic treatment worsened motor function and decreased survival in the SOD1 mice, which is consistent with studies using high-dose antibiotics. We also found that co-housing SOD1 mice with wildtype mice had no effect on disease progression. We investigated changes in the microbiome and found that antibiotics reduced\n                      <jats:italic>Akkermansia<\/jats:italic>\n                      and butyrate-producing bacteria, which may be beneficial in ALS, and cohousing had little effect on the microbiome. To investigate changes in CNS resident immune cells, we sorted spinal cord microglia and found that antibiotics downregulated homeostatic genes and increased neurodegenerative disease genes in SOD1 mice. Furthermore, antibiotic-induced changes in microglia preceded changes in motor function, suggesting that this may be contributing to disease progression.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our findings suggest that the microbiota play a protective role in the SOD1 model of ALS by restraining MGnD microglia, which is opposite to other neurologic disease models, and sheds new light on the importance of disease-specific interactions between microbiota and microglia.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40168-022-01232-z","type":"journal-article","created":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T21:02:29Z","timestamp":1646946149000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["The microbiota restrains neurodegenerative microglia in a model of amyotrophic lateral sclerosis"],"prefix":"10.1186","volume":"10","author":[{"given":"Laura M.","family":"Cox","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narghes","family":"Calcagno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Gauthier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Madore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oleg","family":"Butovsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard L.","family":"Weiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,11]]},"reference":[{"key":"1232_CR1","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/nrneurol.2013.203","volume":"9","author":"A Al-Chalabi","year":"2013","unstructured":"Al-Chalabi A, Hardiman O. The epidemiology of ALS: a conspiracy of genes, environment and time. Nat Rev Neurol. 2013;9:617\u201328. https:\/\/doi.org\/10.1038\/nrneurol.2013.203.","journal-title":"Nat Rev Neurol"},{"key":"1232_CR2","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.ddmod.2018.10.001","volume":"25-26","author":"J Stephenson","year":"2017","unstructured":"Stephenson J, Amor S. Modelling amyotrophic lateral sclerosis in mice. Drug Discov Today Dis Models. 2017;25-26:35\u201344. https:\/\/doi.org\/10.1016\/j.ddmod.2018.10.001.","journal-title":"Drug Discov Today Dis Models"},{"key":"1232_CR3","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1056\/NEJMra1600266","volume":"375","author":"SV Lynch","year":"2016","unstructured":"Lynch SV, Pedersen O. The human intestinal microbiome in health and disease. N Engl J Med. 2016;375:2369\u201379. https:\/\/doi.org\/10.1056\/NEJMra1600266.","journal-title":"N Engl J Med"},{"key":"1232_CR4","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s13311-017-0598-8","volume":"15","author":"LM Cox","year":"2018","unstructured":"Cox LM, Weiner HL. Microbiota signaling pathways that influence neurologic disease. Neurotherapeutics. 2018;15:135\u201345. https:\/\/doi.org\/10.1007\/s13311-017-0598-8.","journal-title":"Neurotherapeutics"},{"key":"1232_CR5","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.neurobiolaging.2017.09.023","volume":"61","author":"D Brenner","year":"2018","unstructured":"Brenner D, et al. The fecal microbiome of ALS patients. Neurobiol Aging. 2018;61:132\u20137. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2017.09.023.","journal-title":"Neurobiol Aging"},{"key":"1232_CR6","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1038\/s41586-019-1443-5","volume":"572","author":"E Blacher","year":"2019","unstructured":"Blacher E, et al. Potential roles of gut microbiome and metabolites in modulating ALS in mice. Nature. 2019;572:474\u201380. https:\/\/doi.org\/10.1038\/s41586-019-1443-5.","journal-title":"Nature"},{"key":"1232_CR7","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1080\/21678421.2020.1828475","volume":"22","author":"K Nicholson","year":"2021","unstructured":"Nicholson K, et al. The human gut microbiota in people with amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2021;22:186\u201394. https:\/\/doi.org\/10.1080\/21678421.2020.1828475.","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"1232_CR8","doi-asserted-by":"publisher","unstructured":"Rowin J, Xia Y, Jung B, Sun J. Gut inflammation and dysbiosis in human motor neuron disease. Physiol Rep. 2017;5. https:\/\/doi.org\/10.14814\/phy2.13443.","DOI":"10.14814\/phy2.13443"},{"key":"1232_CR9","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1038\/nature10554","volume":"479","author":"K Berer","year":"2011","unstructured":"Berer K, et al. Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination. Nature. 2011;479:538\u201341. https:\/\/doi.org\/10.1038\/nature10554.","journal-title":"Nature"},{"key":"1232_CR10","doi-asserted-by":"publisher","first-page":"10411","DOI":"10.1038\/s41598-017-11047-w","volume":"7","author":"MR Minter","year":"2017","unstructured":"Minter MR, et al. Antibiotic-induced perturbations in microbial diversity during post-natal development alters amyloid pathology in an aged APPSWE\/PS1DeltaE9 murine model of Alzheimer's disease. Sci Rep. 2017;7:10411. https:\/\/doi.org\/10.1038\/s41598-017-11047-w.","journal-title":"Sci Rep"},{"key":"1232_CR11","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1016\/j.cell.2016.11.018","volume":"167","author":"TR Sampson","year":"2016","unstructured":"Sampson TR, et al. Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson\u2019s disease. Cell. 2016;167:1469\u20131480.e1412. https:\/\/doi.org\/10.1016\/j.cell.2016.11.018.","journal-title":"Cell"},{"issue":"Suppl 1","key":"1232_CR12","doi-asserted-by":"publisher","first-page":"4615","DOI":"10.1073\/pnas.1000082107","volume":"108","author":"YK Lee","year":"2011","unstructured":"Lee YK, Menezes JS, Umesaki Y, Mazmanian SK. Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A. 2011;108(Suppl 1):4615\u201322. https:\/\/doi.org\/10.1073\/pnas.1000082107.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1232_CR13","doi-asserted-by":"publisher","first-page":"4668","DOI":"10.4049\/jimmunol.1501664","volume":"195","author":"PG Miller","year":"2015","unstructured":"Miller PG, Bonn MB, Franklin CL, Ericsson AC, McKarns SC. TNFR2 deficiency acts in concert with gut microbiota to precipitate spontaneous sex-biased central nervous system demyelinating autoimmune disease. J Immunol. 2015;195:4668\u201384. https:\/\/doi.org\/10.4049\/jimmunol.1501664.","journal-title":"J Immunol"},{"key":"1232_CR14","doi-asserted-by":"publisher","first-page":"103","DOI":"10.4161\/gmic.1.2.11515","volume":"1","author":"J Ochoa-Reparaz","year":"2010","unstructured":"Ochoa-Reparaz J, Mielcarz DW, Haque-Begum S, Kasper LH. Induction of a regulatory B cell population in experimental allergic encephalomyelitis by alteration of the gut commensal microflora. Gut Microbes. 2010;1:103\u20138. https:\/\/doi.org\/10.4161\/gmic.1.2.11515.","journal-title":"Gut Microbes"},{"key":"1232_CR15","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1111\/ene.13986","volume":"26","author":"J Sun","year":"2019","unstructured":"Sun J, et al. Antibiotics use and risk of amyotrophic lateral sclerosis in Sweden. Eur J Neurol. 2019;26:1355\u201361. https:\/\/doi.org\/10.1111\/ene.13986.","journal-title":"Eur J Neurol"},{"key":"1232_CR16","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.immuni.2017.08.008","volume":"47","author":"S Krasemann","year":"2017","unstructured":"Krasemann S, et al. The TREM2-APOE pathway drives the transcriptional phenotype of dysfunctional microglia in neurodegenerative diseases. Immunity. 2017;47:566\u2013581.e569. https:\/\/doi.org\/10.1016\/j.immuni.2017.08.008.","journal-title":"Immunity"},{"key":"1232_CR17","first-page":"4","volume":"30","author":"SH Appel","year":"2011","unstructured":"Appel SH, Zhao W, Beers DR, Henkel JS. The microglial-motoneuron dialogue in ALS. Acta Myol. 2011;30:4\u20138.","journal-title":"Acta Myol"},{"key":"1232_CR18","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1126\/science.1123511","volume":"312","author":"S Boillee","year":"2006","unstructured":"Boillee S, et al. Onset and progression in inherited ALS determined by motor neurons and microglia. Science. 2006;312:1389\u201392.","journal-title":"Science"},{"key":"1232_CR19","doi-asserted-by":"publisher","first-page":"e39216","DOI":"10.1371\/journal.pone.0039216","volume":"7","author":"J Brettschneider","year":"2012","unstructured":"Brettschneider J, et al. Microglial activation correlates with disease progression and upper motor neuron clinical symptoms in amyotrophic lateral sclerosis. PLoS One. 2012;7:e39216. https:\/\/doi.org\/10.1371\/journal.pone.0039216.","journal-title":"PLoS One"},{"key":"1232_CR20","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1002\/ana.24304","volume":"77","author":"O Butovsky","year":"2015","unstructured":"Butovsky O, et al. Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice. Ann Neurol. 2015;77:75\u201399. https:\/\/doi.org\/10.1002\/ana.24304.","journal-title":"Ann Neurol"},{"key":"1232_CR21","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1172\/JCI62636","volume":"122","author":"O Butovsky","year":"2012","unstructured":"Butovsky O, et al. Modulating inflammatory monocytes with a unique microRNA gene signature ameliorates murine ALS. J Clin Invest. 2012;122:3063\u201387. https:\/\/doi.org\/10.1172\/JCI62636.","journal-title":"J Clin Invest"},{"key":"1232_CR22","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.nbd.2003.12.012","volume":"15","author":"MR Turner","year":"2004","unstructured":"Turner MR, et al. Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C](R)-PK11195 positron emission tomography study. Neurobiol Dis. 2004;15:601\u20139. https:\/\/doi.org\/10.1016\/j.nbd.2003.12.012.","journal-title":"Neurobiol Dis"},{"key":"1232_CR23","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1002\/ana.10805","volume":"55","author":"JS Henkel","year":"2004","unstructured":"Henkel JS, et al. Presence of dendritic cells, MCP-1, and activated microglia\/macrophages in amyotrophic lateral sclerosis spinal cord tissue. Ann Neurol. 2004;55:221\u201335.","journal-title":"Ann Neurol"},{"key":"1232_CR24","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1111\/j.1468-1331.2009.02560.x","volume":"16","author":"J Kuhle","year":"2009","unstructured":"Kuhle J, et al. Increased levels of inflammatory chemokines in amyotrophic lateral sclerosis. Eur J Neurol. 2009;16:771\u20134. https:\/\/doi.org\/10.1111\/j.1468-1331.2009.02560.x.","journal-title":"Eur J Neurol"},{"key":"1232_CR25","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1002\/mus.21683","volume":"42","author":"H Ryberg","year":"2010","unstructured":"Ryberg H, et al. Discovery and verification of amyotrophic lateral sclerosis biomarkers by proteomics. Muscle Nerve. 2010;42:104\u201311. https:\/\/doi.org\/10.1002\/mus.21683.","journal-title":"Muscle Nerve"},{"key":"1232_CR26","doi-asserted-by":"publisher","first-page":"7594","DOI":"10.1073\/pnas.0802556105","volume":"105","author":"K Yamanaka","year":"2008","unstructured":"Yamanaka K, et al. Mutant SOD1 in cell types other than motor neurons and oligodendrocytes accelerates onset of disease in ALS mice. Proc Natl Acad Sci U S A. 2008;105:7594\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1232_CR27","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1038\/nn.4030","volume":"18","author":"D Erny","year":"2015","unstructured":"Erny D, et al. Host microbiota constantly control maturation and function of microglia in the CNS. Nat Neurosci. 2015;18:965\u201377. https:\/\/doi.org\/10.1038\/nn.4030.","journal-title":"Nat Neurosci"},{"key":"1232_CR28","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1084\/jem.20182386","volume":"216","author":"HB Dodiya","year":"2019","unstructured":"Dodiya HB, et al. Sex-specific effects of microbiome perturbations on cerebral Abeta amyloidosis and microglia phenotypes. J Exp Med. 2019;216:1542\u201360. https:\/\/doi.org\/10.1084\/jem.20182386.","journal-title":"J Exp Med"},{"key":"1232_CR29","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/s41586-020-2288-7","volume":"582","author":"A Burberry","year":"2020","unstructured":"Burberry A, et al. C9orf72 suppresses systemic and neural inflammation induced by gut bacteria. Nature. 2020;582:89\u201394. https:\/\/doi.org\/10.1038\/s41586-020-2288-7.","journal-title":"Nature"},{"key":"1232_CR30","doi-asserted-by":"publisher","first-page":"30028","DOI":"10.1038\/srep30028","volume":"6","author":"MR Minter","year":"2016","unstructured":"Minter MR, et al. Antibiotic-induced perturbations in gut microbial diversity influences neuro-inflammation and amyloidosis in a murine model of Alzheimer\u2019s disease. Sci Rep. 2016;6:30028. https:\/\/doi.org\/10.1038\/srep30028.","journal-title":"Sci Rep"},{"key":"1232_CR31","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/s41422-019-0216-x","volume":"29","author":"X Wang","year":"2019","unstructured":"Wang X, et al. Sodium oligomannate therapeutically remodels gut microbiota and suppresses gut bacterial amino acids-shaped neuroinflammation to inhibit Alzheimer\u2019s disease progression. Cell Res. 2019;29:787\u2013803. https:\/\/doi.org\/10.1038\/s41422-019-0216-x.","journal-title":"Cell Res"},{"key":"1232_CR32","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1038\/nm.4068","volume":"22","author":"C Benakis","year":"2016","unstructured":"Benakis C, et al. Commensal microbiota affects ischemic stroke outcome by regulating intestinal gammadelta T cells. Nat Med. 2016;22:516\u201323. https:\/\/doi.org\/10.1038\/nm.4068.","journal-title":"Nat Med"},{"key":"1232_CR33","doi-asserted-by":"publisher","unstructured":"Regen T, et al. IL-17 controls central nervous system autoimmunity through the intestinal microbiome. Sci Immunol. 2021;6. https:\/\/doi.org\/10.1126\/sciimmunol.aaz6563.","DOI":"10.1126\/sciimmunol.aaz6563"},{"key":"1232_CR34","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s40168-019-0733-3","volume":"7","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, et al. Gut microbiota from NLRP3-deficient mice ameliorates depressive-like behaviors by regulating astrocyte dysfunction via circHIPK2. Microbiome. 2019;7:116. https:\/\/doi.org\/10.1186\/s40168-019-0733-3.","journal-title":"Microbiome"},{"key":"1232_CR35","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1080\/17482960701856300","volume":"9","author":"S Scott","year":"2008","unstructured":"Scott S, et al. Design, power, and interpretation of studies in the standard murine model of ALS. Amyotroph Lateral Scler. 2008;9:4\u201315. https:\/\/doi.org\/10.1080\/17482960701856300.","journal-title":"Amyotroph Lateral Scler"},{"key":"1232_CR36","doi-asserted-by":"publisher","unstructured":"Hatzipetros T, et al. A quick phenotypic neurological scoring system for evaluating disease progression in the SOD1-G93A mouse model of ALS. J Vis Exp. 2015. https:\/\/doi.org\/10.3791\/53257.","DOI":"10.3791\/53257"},{"key":"1232_CR37","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/nn.3599","volume":"17","author":"O Butovsky","year":"2014","unstructured":"Butovsky O, et al. Identification of a unique TGF-beta-dependent molecular and functional signature in microglia. Nat Neurosci. 2014;17:131\u201343. https:\/\/doi.org\/10.1038\/nn.3599.","journal-title":"Nat Neurosci"},{"key":"1232_CR38","doi-asserted-by":"publisher","unstructured":"Richner M, Jager SB, Siupka P, Vaegter CB. Hydraulic extrusion of the spinal cord and isolation of dorsal root ganglia in rodents. J Vis Exp. 2017;55226. https:\/\/doi.org\/10.3791\/55226.","DOI":"10.3791\/55226"},{"key":"1232_CR39","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1038\/nmeth.2639","volume":"10","author":"S Picelli","year":"2013","unstructured":"Picelli S, et al. Smart-seq2 for sensitive full-length transcriptome profiling in single cells. Nat Methods. 2013;10:1096\u20138. https:\/\/doi.org\/10.1038\/nmeth.2639.","journal-title":"Nat Methods"},{"key":"1232_CR40","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/nprot.2012.016","volume":"7","author":"C Trapnell","year":"2012","unstructured":"Trapnell C, et al. Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks. Nature protocols. 2012;7:562\u201378. https:\/\/doi.org\/10.1038\/nprot.2012.016.","journal-title":"Nature protocols"},{"key":"1232_CR41","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1093\/bioinformatics\/btt703","volume":"30","author":"A Kramer","year":"2014","unstructured":"Kramer A, Green J, Pollard J Jr, Tugendreich S. Causal analysis approaches in ingenuity pathway analysis. Bioinformatics. 2014;30:523\u201330. https:\/\/doi.org\/10.1093\/bioinformatics\/btt703.","journal-title":"Bioinformatics"},{"key":"1232_CR42","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1038\/ismej.2012.8","volume":"6","author":"JG Caporaso","year":"2012","unstructured":"Caporaso JG, et al. Ultra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms. ISME J. 2012;6:1621\u20134. https:\/\/doi.org\/10.1038\/ismej.2012.8.","journal-title":"ISME J"},{"key":"1232_CR43","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1002\/ana.26084","volume":"89","author":"LM Cox","year":"2021","unstructured":"Cox LM, et al. Gut microbiome in progressive multiple sclerosis. Ann Neurol. 2021;89:1195\u2013211. https:\/\/doi.org\/10.1002\/ana.26084.","journal-title":"Ann Neurol"},{"key":"1232_CR44","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/nmeth.f.303","volume":"7","author":"JG Caporaso","year":"2010","unstructured":"Caporaso JG, et al. QIIME allows analysis of high-throughput community sequencing data. Nat Methods. 2010;7:335\u20136. https:\/\/doi.org\/10.1038\/nmeth.f.303.","journal-title":"Nat Methods"},{"key":"1232_CR45","doi-asserted-by":"publisher","first-page":"D643","DOI":"10.1093\/nar\/gkt1209","volume":"42","author":"P Yilmaz","year":"2014","unstructured":"Yilmaz P, et al. The SILVA and \u201cAll-species Living Tree Project (LTP)\u201d taxonomic frameworks. Nucleic Acids Res. 2014;42:D643\u20138. https:\/\/doi.org\/10.1093\/nar\/gkt1209.","journal-title":"Nucleic Acids Res"},{"key":"1232_CR46","doi-asserted-by":"publisher","first-page":"R60","DOI":"10.1186\/gb-2011-12-6-r60","volume":"12","author":"N Segata","year":"2011","unstructured":"Segata N, et al. Metagenomic biomarker discovery and explanation. Genome Biol. 2011;12:R60. https:\/\/doi.org\/10.1186\/gb-2011-12-6-r60.","journal-title":"Genome Biol"},{"key":"1232_CR47","doi-asserted-by":"publisher","unstructured":"Bokulich NA, et al. q2-longitudinal: longitudinal and paired-sample analyses of microbiome data. mSystems. 2018;3. https:\/\/doi.org\/10.1128\/mSystems.00219-18.","DOI":"10.1128\/mSystems.00219-18"},{"key":"1232_CR48","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.cell.2014.05.052","volume":"158","author":"LM Cox","year":"2014","unstructured":"Cox LM, et al. Altering the intestinal microbiota during a critical developmental window has lasting metabolic consequences. Cell. 2014;158:705\u201321. https:\/\/doi.org\/10.1016\/j.cell.2014.05.052.","journal-title":"Cell"},{"key":"1232_CR49","doi-asserted-by":"publisher","unstructured":"Abriouel H, et al. The controversial nature of the Weissella genus: technological and functional aspects versus whole genome analysis-based pathogenic potential for their application in food and health. Front Microbiol. 2015;6. https:\/\/doi.org\/10.3389\/fmicb.2015.01197.","DOI":"10.3389\/fmicb.2015.01197"},{"key":"1232_CR50","doi-asserted-by":"publisher","first-page":"110995","DOI":"10.1016\/j.nut.2020.110995","volume":"79-80","author":"D Perez Vis\u00f1uk","year":"2020","unstructured":"Perez Vis\u00f1uk D, Savoy de Giori G, LeBlanc JG, de Moreno de LeBlanc A. Neuroprotective effects associated with immune modulation by selected lactic acid bacteria in a Parkinson\u2019s disease model. Nutrition. 2020;79-80:110995. https:\/\/doi.org\/10.1016\/j.nut.2020.110995.","journal-title":"Nutrition"},{"key":"1232_CR51","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1002\/jlb.4mr1118-419r","volume":"106","author":"V Gres","year":"2019","unstructured":"Gres V, Kolter J, Erny D, Henneke P. The role of CNS macrophages in streptococcal meningoencephalitis. J Leukoc Biol. 2019;106:209\u201318. https:\/\/doi.org\/10.1002\/jlb.4mr1118-419r.","journal-title":"J Leukoc Biol"},{"key":"1232_CR52","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1038\/nature18283","volume":"534","author":"MJ Vasek","year":"2016","unstructured":"Vasek MJ, et al. A complement-microglial axis drives synapse loss during virus-induced memory impairment. Nature. 2016;534:538\u201343. https:\/\/doi.org\/10.1038\/nature18283.","journal-title":"Nature"},{"key":"1232_CR53","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1097\/NEN.0b013e3181fc9aea","volume":"69","author":"T Philips","year":"2010","unstructured":"Philips T, et al. Microglial upregulation of progranulin as a marker of motor neuron degeneration. J Neuropathol Exp Neurol. 2010;69:1191\u2013200. https:\/\/doi.org\/10.1097\/NEN.0b013e3181fc9aea.","journal-title":"J Neuropathol Exp Neurol"},{"key":"1232_CR54","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1016\/j.neurobiolaging.2013.03.027","volume":"34","author":"S Herdewyn","year":"2013","unstructured":"Herdewyn S, De Muynck L, Van Den Bosch L, Robberecht W, Van Damme P. Progranulin does not affect motor neuron degeneration in mutant SOD1 mice and rats. Neurobiol Aging. 2013;34:2302\u20133. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2013.03.027.","journal-title":"Neurobiol Aging"},{"key":"1232_CR55","doi-asserted-by":"publisher","first-page":"3955","DOI":"10.1172\/JCI63113","volume":"122","author":"LH Martens","year":"2012","unstructured":"Martens LH, et al. Progranulin deficiency promotes neuroinflammation and neuron loss following toxin-induced injury. J Clin Invest. 2012;122:3955\u20139. https:\/\/doi.org\/10.1172\/JCI63113.","journal-title":"J Clin Invest"},{"key":"1232_CR56","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1073\/pnas.1616332114","volume":"114","author":"S Jinn","year":"2017","unstructured":"Jinn S, et al. TMEM175 deficiency impairs lysosomal and mitochondrial function and increases \u03b1-synuclein aggregation. Proc Natl Acad Sci U S A. 2017;114:2389\u201394. https:\/\/doi.org\/10.1073\/pnas.1616332114.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1232_CR57","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.celrep.2013.06.018","volume":"4","author":"IM Chiu","year":"2013","unstructured":"Chiu IM, et al. A neurodegeneration-specific gene-expression signature of acutely isolated microglia from an amyotrophic lateral sclerosis mouse model. Cell Rep. 2013;4:385\u2013401. https:\/\/doi.org\/10.1016\/j.celrep.2013.06.018.","journal-title":"Cell Rep"},{"key":"1232_CR58","doi-asserted-by":"publisher","first-page":"572","DOI":"10.4049\/jimmunol.1601247","volume":"198","author":"E Blacher","year":"2017","unstructured":"Blacher E, Levy M, Tatirovsky E, Elinav E. Microbiome-modulated metabolites at the interface of host immunity. J Immunol. 2017;198:572\u201380. https:\/\/doi.org\/10.4049\/jimmunol.1601247.","journal-title":"J Immunol"},{"key":"1232_CR59","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.cell.2018.06.051","volume":"174","author":"CA Olson","year":"2018","unstructured":"Olson CA, et al. The gut microbiota mediates the anti-seizure effects of the ketogenic diet. Cell. 2018;174:497. https:\/\/doi.org\/10.1016\/j.cell.2018.06.051.","journal-title":"Cell"},{"key":"1232_CR60","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/s41387-020-0115-8","volume":"10","author":"Z Ou","year":"2020","unstructured":"Ou Z, et al. Protective effects of Akkermansia muciniphila on cognitive deficits and amyloid pathology in a mouse model of Alzheimer\u2019s disease. Nutr Diabetes. 2020;10:12. https:\/\/doi.org\/10.1038\/s41387-020-0115-8.","journal-title":"Nutr Diabetes"},{"key":"1232_CR61","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.clinthera.2016.12.014","volume":"39","author":"YG Zhang","year":"2017","unstructured":"Zhang YG, et al. Target intestinal microbiota to alleviate disease progression in amyotrophic lateral sclerosis. Clin Ther. 2017;39:322\u201336. https:\/\/doi.org\/10.1016\/j.clinthera.2016.12.014.","journal-title":"Clin Ther"},{"key":"1232_CR62","first-page":"187","volume":"59","author":"M Berard","year":"2009","unstructured":"Berard M, et al. Ralstonia pickettii-induced ataxia in immunodeficient mice. Comp Med. 2009;59:187\u201391.","journal-title":"Comp Med"},{"key":"1232_CR63","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/S1474-4422(07)70270-3","volume":"6","author":"PH Gordon","year":"2007","unstructured":"Gordon PH, et al. Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial. Lancet Neurol. 2007;6:1045\u201353. https:\/\/doi.org\/10.1016\/S1474-4422(07)70270-3.","journal-title":"Lancet Neurol"}],"container-title":["Microbiome"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40168-022-01232-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40168-022-01232-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40168-022-01232-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,17]],"date-time":"2022-05-17T23:00:42Z","timestamp":1652828442000},"score":1,"resource":{"primary":{"URL":"https:\/\/microbiomejournal.biomedcentral.com\/articles\/10.1186\/s40168-022-01232-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,11]]},"references-count":63,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1232"],"URL":"https:\/\/doi.org\/10.1186\/s40168-022-01232-z","relation":{},"ISSN":["2049-2618"],"issn-type":[{"value":"2049-2618","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,11]]},"assertion":[{"value":"8 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal studies were carried out in accordance with IACUC-approved protocols.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"47"}}